Plain-English translation of NCT03911297 on ClinicalTrials.gov ↗ ·
Researchers are trying to better understand polycystic ovary syndrome (PCOS) by collecting detailed blood and urine samples from about 1,000 women with the condition. By analyzing hormone levels and metabolic markers in these samples, they hope to identify distinct groups of PCOS patients who share similar characteristics—which could help doctors predict who is at highest risk for future metabolic problems like diabetes.
Right now, doctors don't have reliable, measurable markers to predict which women with PCOS will develop metabolic disease in the future. This study aims to fill that gap by using advanced computer analysis to find patterns in hormone and metabolic data that could serve as early warning signs.
You likely qualify if…
You likely don't qualify if…
As a participant, you would provide blood and urine samples for detailed analysis of your hormone levels and metabolic markers. You would need to avoid certain medications and hormonal contraceptives before your visit, and researchers will ask about your medical history. The study is observational, meaning you are not taking any new medication—researchers are simply collecting samples and data to analyze patterns in PCOS.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United Kingdom